BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sartori SB, Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol Ther 2019;204:107402. [PMID: 31470029 DOI: 10.1016/j.pharmthera.2019.107402] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 24.3] [Reference Citation Analysis]
Number Citing Articles
1 Sharma S, Hegde P, Panda S, Orimoloye MO, Aldrich CC. Drugging the microbiome: targeting small microbiome molecules. Current Opinion in Microbiology 2023;71:102234. [DOI: 10.1016/j.mib.2022.102234] [Reference Citation Analysis]
2 Nguyen LTH, Nguyen NPK, Tran KN, Shin H, Yang I. Anxiolytic-like Effect of Inhaled Cinnamon Essential Oil and Its Main Component Cinnamaldehyde in Animal Models. Molecules 2022;27:7997. [DOI: 10.3390/molecules27227997] [Reference Citation Analysis]
3 Puri V, Kanojia N, Sharma A, Huanbutta K, Dheer D, Sangnim T. Natural product-based pharmacological studies for neurological disorders. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1011740] [Reference Citation Analysis]
4 Sah A, Rooney S, Kharitonova M, Sartori SB, Wolf SA, Singewald N. Enriched Environment Attenuates Enhanced Trait Anxiety in Association with Normalization of Aberrant Neuro-Inflammatory Events. IJMS 2022;23:13052. [DOI: 10.3390/ijms232113052] [Reference Citation Analysis]
5 Vieira MPS, Silva OBS, Souza GF, Cavalcante GTS, Souza FMA, Gitaí DLG, Castro OW, Nicácio DCSP, Cofré AHR, Amorós MA, Silva AV, Neto JGS, Silva AHQ, Correia WBZGB, Junkes JA, Duarte FS, Guedes JS, Nogueira FCS, Meneghetti MR, Duzzioni M. First evaluation of the anxiolytic-like effects of a bromazepam‑palladium complex in mice. J Inorg Biochem 2022;237:112012. [PMID: 36162209 DOI: 10.1016/j.jinorgbio.2022.112012] [Reference Citation Analysis]
6 Gasparyan A, Navarro D, Navarrete F, Manzanares J. Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies. Neuropharmacology 2022;218:109211. [PMID: 35973598 DOI: 10.1016/j.neuropharm.2022.109211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, Domschke K, Eriksson E, Fineberg NA, Hättenschwiler J, Hollander E, Kaiya H, Karavaeva T, Kasper S, Katzman M, Kim YK, Inoue T, Lim L, Masdrakis V, Menchón JM, Miguel EC, Möller HJ, Nardi AE, Pallanti S, Perna G, Rujescu D, Starcevic V, Stein DJ, Tsai SJ, Van Ameringen M, Vasileva A, Wang Z, Zohar J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders. World J Biol Psychiatry 2022;:1-39. [PMID: 35900161 DOI: 10.1080/15622975.2022.2086295] [Reference Citation Analysis]
8 Alzarea SI, Qasim S, Uttra AM, Khan YH, Aljoufi FA, Ahmed SR, Alanazi M, Malhi TH. Network Pharmacology and Molecular Docking Based Prediction of Mechanism of Pharmacological Attributes of Glutinol. Processes 2022;10:1492. [DOI: 10.3390/pr10081492] [Reference Citation Analysis]
9 Vitalis T, Verney C. Roles of the Serotoninergic System in Coping with Traumatic Stress. Serotonin and the CNS - New Developments in Pharmacology and Therapeutics 2022. [DOI: 10.5772/intechopen.97221] [Reference Citation Analysis]
10 Shiner B, Huybrechts K, Gui J, Rozema L, Forehand J, Watts BV, Jiang T, Hoyt JE, Esteves J, Schnurr PP, Ray K, Gradus JL. Comparative Effectiveness of Direct-Acting Antivirals for Posttraumatic Stress Disorder in VA Patients with Hepatitis C Virus Infection. Am J Epidemiol 2022:kwac104. [PMID: 35689641 DOI: 10.1093/aje/kwac104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hur J, Kuhn M, Grogans SE, Anderson AS, Islam S, Kim HC, Tillman RM, Fox AS, Smith JF, DeYoung KA, Shackman AJ. Anxiety-Related Frontocortical Activity Is Associated With Dampened Stressor Reactivity in the Real World. Psychol Sci 2022;:9567976211056635. [PMID: 35657777 DOI: 10.1177/09567976211056635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Budgett RF, Bakker G, Sergeev E, Bennett KA, Bradley SJ. Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases? Front Pharmacol 2022;13:893422. [PMID: 35645791 DOI: 10.3389/fphar.2022.893422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Noah L, Morel V, Bertin C, Pouteau E, Macian N, Dualé C, Pereira B, Pickering G. Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study. Nutrients 2022;14:1863. [PMID: 35565828 DOI: 10.3390/nu14091863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Jia S, Hou Y, Wang D, Zhao X. Flavonoids for depression and anxiety: a systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2022.2057914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Yilmaz C, İkizer G. Duygudurum ve Anksiyete Bozukluklarında Psikonöroimmünolojik Süreçler ve Psikoterapi ile İlişkisi. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 2022;14:96-107. [DOI: 10.18863/pgy.943148] [Reference Citation Analysis]
16 Jacobs DS, Allen MC, Park J, Moghaddam B. Learning of probabilistic punishment as a model of anxiety produces changes in action but not punishment encoding in the dmPFC and VTA.. [DOI: 10.1101/2022.03.29.486234] [Reference Citation Analysis]
17 Lurati AR. Management of Obsessive Compulsive Symptoms in a Patient Diagnosed With Bipolar 1 Disorder and a History of Migraines. The Journal for Nurse Practitioners 2022. [DOI: 10.1016/j.nurpra.2022.01.009] [Reference Citation Analysis]
18 Melcer T, Walker GJ, Dye JL, Walrath B, MacGregor AJ, Perez K, Galarneau MR. Is Prehospital Ketamine Associated With a Change in the Prognosis of PTSD? Mil Med 2022:usac014. [PMID: 35104347 DOI: 10.1093/milmed/usac014] [Reference Citation Analysis]
19 Zhou B, Jin G, Pang X, Mo Q, Bao J, Liu T, Wu J, Xie R, Liu X, Liu J, Yang H, Xu X, Wang B, Cao H. Lactobacillus rhamnosus GG colonization in early life regulates gut-brain axis and relieves anxiety-like behavior in adulthood. Pharmacol Res 2022;:106090. [PMID: 35065201 DOI: 10.1016/j.phrs.2022.106090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Witkin JM, Lippa A, Smith JL, Jin X, Ping X, Biggerstaff A, Kivell BM, Knutson DE, Sharmin D, Pandey KP, Mian MY, Cook JM, Cerne R. The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders. Pharmacol Biochem Behav 2022;:173321. [PMID: 35041859 DOI: 10.1016/j.pbb.2021.173321] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Bulteau S, Laurin A, Bach-Ngohou K, Péré M, Vibet MA, Hardouin JB, Sebille V, Lagalice L, Faurel-Paul É, Acier D, Rabeyron T, Riche VP, Sauvaget A, Melki F, Vigier T, Perreira Da Silva M, Charlet O, Prié Y. Feasibility of Combining Transcranial Direct Current Stimulation and Active Fully Embodied Virtual Reality for Visual Height Intolerance: A Double-Blind Randomized Controlled Study. J Clin Med 2022;11:345. [PMID: 35054039 DOI: 10.3390/jcm11020345] [Reference Citation Analysis]
22 Saral Ö, Şahin H, Saral S, Alkanat M, Akyıldız K, Topçu A, Yılmaz A. Bee pollen increases hippocampal brain-derived neurotrophic factor and suppresses neuroinflammation in adult rats with chronic immobilization stress. Neurosci Lett 2022;766:136342. [PMID: 34774703 DOI: 10.1016/j.neulet.2021.136342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ou G, Li Q, Zhu L, Zhang Y, Liu Y, Li X, Du L, Jin Y. Intranasal Hydrogel of Armodafinil Hydroxypropyl-β-Cyclodextrin Inclusion Complex for the Treatment of Post-Traumatic Stress Disorder. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.01.009] [Reference Citation Analysis]
24 Popoli M, Ieraci A, Musazzi L. The Role of the Glutamate System in Posttraumatic Stress Disorder and Glutamate-Based Treatments. Glutamate and Neuropsychiatric Disorders 2022. [DOI: 10.1007/978-3-030-87480-3_5] [Reference Citation Analysis]
25 Namkung H, Thomas KL, Hall J, Sawa A. Parsing neural circuits of fear learning and extinction across basic and clinical neuroscience: towards better translation. Neurosci Biobehav Rev 2021:S0149-7634(21)00573-X. [PMID: 34921863 DOI: 10.1016/j.neubiorev.2021.12.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Chugh V, Vijaya Krishna K, Pandit A. Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation. ACS Nano 2021. [PMID: 34699181 DOI: 10.1021/acsnano.1c03800] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 15.0] [Reference Citation Analysis]
27 Scherf-Clavel M, Weber H, Deckert J, Erhardt-Lehmann A. The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics. Expert Opin Drug Metab Toxicol 2021;:1-12. [PMID: 34643143 DOI: 10.1080/17425255.2021.1991912] [Reference Citation Analysis]
28 Prinholato da Silva C, Oliveira DD, Benincasa BI, Barbar B, Facchin AL, Beleboni RO. Antidepressant activity of Riparin A in murine model. Behav Pharmacol 2021;32:599-606. [PMID: 34483245 DOI: 10.1097/FBP.0000000000000654] [Reference Citation Analysis]
29 Majid H, Puzik A, Maier T, Merk R, Bartel A, Mueller HC, Burckhardt BB. Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies. Pharmaceutics 2021;13:1409. [PMID: 34575485 DOI: 10.3390/pharmaceutics13091409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Sivolap YP. [Serotonin-norepinephrine reuptake inhibitors in psychiatry and neurology]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:141-6. [PMID: 34481450 DOI: 10.17116/jnevro2021121081141] [Reference Citation Analysis]
31 Murkar A, De Koninck J, Merali Z. Cannabinoids: Revealing their complexity and role in central networks of fear and anxiety. Neurosci Biobehav Rev 2021;131:30-46. [PMID: 34487746 DOI: 10.1016/j.neubiorev.2021.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Esser R, Korn CW, Ganzer F, Haaker J. L-DOPA modulates activity in the vmPFC, nucleus accumbens, and VTA during threat extinction learning in humans. Elife 2021;10:e65280. [PMID: 34473055 DOI: 10.7554/eLife.65280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
33 Rusz C, Jîtcă G, Miklos A, Bătrînu M, Ősz BE, Imre S. Current and novel pharmacological therapeutic approaches in Post-Traumatic Stress Disorder. A brief review. Acta Marisiensis - Seria Medica 2021;67:143-148. [DOI: 10.2478/amma-2021-0023] [Reference Citation Analysis]
34 Peterson PR, Ho R. Nervous and Scared. Physician Assistant Clinics 2021;6:479-493. [DOI: 10.1016/j.cpha.2021.03.002] [Reference Citation Analysis]
35 Akhtar A, Pilkhwal Sah S. Advances in the pharmacotherapeutic management of post-traumatic stress disorder. Expert Opin Pharmacother 2021;:1-12. [PMID: 34124975 DOI: 10.1080/14656566.2021.1935871] [Reference Citation Analysis]
36 Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Focus (Am Psychiatr Publ) 2021;19:222-42. [PMID: 34690588 DOI: 10.1176/appi.focus.19203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
37 Ressler KJ. Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders. FOC 2021;19:247-255. [DOI: 10.1176/appi.focus.19205] [Reference Citation Analysis]
38 Voronin MV, Vakhitova YV, Tsypysheva IP, Tsypyshev DO, Rybina IV, Kurbanov RD, Abramova EV, Seredenin SB. Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole. Int J Mol Sci 2021;22:5455. [PMID: 34064275 DOI: 10.3390/ijms22115455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Majid H, Puzik A, Maier T, Eberhard D, Bartel A, Mueller HC, Burckhardt BB. Exploring the transmucosal permeability of cyclobenzaprine: A comparative preformulation by standardized and controlled ex vivo and in vitro permeation studies. Int J Pharm 2021;601:120574. [PMID: 33831487 DOI: 10.1016/j.ijpharm.2021.120574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Lago TR, Brownstein MJ, Page E, Beydler E, Manbeck A, Beale A, Roberts C, Balderston N, Damiano E, Pineles SL, Simon N, Ernst M, Grillon C. The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study. Psychopharmacology (Berl) 2021;238:2393-403. [PMID: 33970290 DOI: 10.1007/s00213-021-05861-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Maltsev DV, Spasov AA, Miroshnikov MV, Skripka MO. Current Approaches to the Search of Anxiolytic Drugs. Russ J Bioorg Chem 2021;47:622-652. [DOI: 10.1134/s1068162021030122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Caldirola D, Alciati A, Cuniberti F, Perna G. Experimental Drugs for Panic Disorder: An Updated Systematic Review. J Exp Pharmacol 2021;13:441-59. [PMID: 33889031 DOI: 10.2147/JEP.S261403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Gromer D, Kiser DP, Pauli P. Thigmotaxis in a virtual human open field test. Sci Rep 2021;11:6670. [PMID: 33758204 DOI: 10.1038/s41598-021-85678-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
44 Garakani A, Freire RC, Murrough JW. Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls. Front Psychiatry 2021;12:662963. [PMID: 33815180 DOI: 10.3389/fpsyt.2021.662963] [Reference Citation Analysis]
45 Hur J, Kuhn M, Grogans SE, Anderson AS, Islam S, Kim HC, Tillman RM, Fox AS, Smith JF, Deyoung KA, Shackman AJ. Anxiety-related frontocortical activity is associated with dampened stressor reactivity in the real world.. [DOI: 10.1101/2021.03.17.435791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Kreutzmann JC, Fendt M. Intranasal oxytocin compensates for estrus cycle-specific reduction of conditioned safety memory in rats: Implications for psychiatric disorders. Neurobiol Stress 2021;14:100313. [PMID: 33778132 DOI: 10.1016/j.ynstr.2021.100313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Cimino C, Maurel OM, Musumeci T, Bonaccorso A, Drago F, Souto EMB, Pignatello R, Carbone C. Essential Oils: Pharmaceutical Applications and Encapsulation Strategies into Lipid-Based Delivery Systems. Pharmaceutics 2021;13:327. [PMID: 33802570 DOI: 10.3390/pharmaceutics13030327] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
48 Gupta PR, Prabhavalkar K. Combination therapy with neuropeptides for the treatment of anxiety disorder. Neuropeptides 2021;86:102127. [PMID: 33607407 DOI: 10.1016/j.npep.2021.102127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Shackman AJ, Fox AS. Two Decades of Anxiety Neuroimaging Research: New Insights and a Look to the Future. Am J Psychiatry 2021;178:106-9. [PMID: 33517754 DOI: 10.1176/appi.ajp.2020.20121733] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
50 Kondev V, Winters N, Patel S. Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches. Int Rev Neurobiol 2021;157:143-93. [PMID: 33648669 DOI: 10.1016/bs.irn.2020.09.007] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
51 Van Schuerbeek A, Vanderhasselt MA, Baeken C, Pierre A, Smolders I, Van Waes V, De Bundel D. Effects of repeated anodal transcranial direct current stimulation on auditory fear extinction in C57BL/6J mice. Brain Stimul 2021;14:250-60. [PMID: 33454396 DOI: 10.1016/j.brs.2021.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
52 Lucchese AC, Sarin LM, Magalhães EJM, Del Sant LC, B Puertas C, Tuena MA, Nakahira C, Fava VA, Delfino R, Surjan J, Steiglich MS, Barbosa M, Abdo G, Cohrs FM, Liberatori A, Del Porto JA, Lacerda AL, B Andreoli S. Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity. J Psychopharmacol 2021;35:142-9. [PMID: 33427015 DOI: 10.1177/0269881120978398] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
53 Larijani B, Parhizkar Roudsari P, Hadavandkhani M, Alavi-Moghadam S, Rezaei-Tavirani M, Goodarzi P, Sayahpour FA, Mohamadi-Jahani F, Arjmand B. Stem cell-based models and therapies: a key approach into schizophrenia treatment. Cell Tissue Bank 2021;22:207-23. [PMID: 33387152 DOI: 10.1007/s10561-020-09888-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
54 Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry 2020;11:595584. [PMID: 33424664 DOI: 10.3389/fpsyt.2020.595584] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 22.5] [Reference Citation Analysis]
55 Esser R, Korn CW, Ganzer F, Haaker J. L-DOPA modulates activity in the vmPFC, Nucleus Accumbens and VTA during threat extinction learning in humans.. [DOI: 10.1101/2020.12.07.414771] [Reference Citation Analysis]
56 Ford CL, Young LJ. Translational opportunities for circuit-based social neuroscience: advancing 21st century psychiatry. Curr Opin Neurobiol 2021;68:1-8. [PMID: 33260106 DOI: 10.1016/j.conb.2020.11.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
57 Fritz EM, Singewald N, De Bundel D. The Good, the Bad and the Unknown Aspects of Ghrelin in Stress Coping and Stress-Related Psychiatric Disorders. Front Synaptic Neurosci 2020;12:594484. [PMID: 33192444 DOI: 10.3389/fnsyn.2020.594484] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
58 Grillon C, Ernst M. A way forward for anxiolytic drug development: Testing candidate anxiolytics with anxiety-potentiated startle in healthy humans. Neurosci Biobehav Rev 2020;119:348-54. [PMID: 33038346 DOI: 10.1016/j.neubiorev.2020.09.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
59 Hommey C, Ma J, Asamani L, Hanson P. The Moderating Effect of Acculturation Strategies on the Relationship Between Newcomer Adjustment and Employee Behavior. Front Psychol 2020;11:2117. [PMID: 32982866 DOI: 10.3389/fpsyg.2020.02117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Maldonado R, Cabañero D, Martín-García E. The endocannabinoid system in modulating fear, anxiety, and stress
. Dialogues Clin Neurosci 2020;22:229-39. [PMID: 33162766 DOI: 10.31887/DCNS.2020.22.3/rmaldonado] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
61 Riaz A, Rasul A, Sarfraz I, Nawaz J, Sadiqa A, Zara R, Gul Khan S, Selamoglu Z. Chemical Biology Toolsets for Drug Discovery and Target Identification. Cheminformatics and its Applications 2020. [DOI: 10.5772/intechopen.91732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Nosková E, Šebela A, Stopková P. Current trends in treatment of generalised anxiety disorder. Psychiatr pro Praxi 2020;21:66-72. [DOI: 10.36290/psy.2020.012] [Reference Citation Analysis]
63 Glue P, Medlicott NJ, Neehoff S, Surman P, Lam F, Hung N, Hung CT. Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study. Ther Adv Psychopharmacol 2020;10:2045125320922474. [PMID: 32523677 DOI: 10.1177/2045125320922474] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
64 Ressler KJ. Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders. Am J Psychiatry 2020;177:214-22. [PMID: 32114783 DOI: 10.1176/appi.ajp.2020.20010055] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 22.0] [Reference Citation Analysis]
65 Sbarski B, Akirav I. Cannabinoids as therapeutics for PTSD. Pharmacol Ther 2020;211:107551. [PMID: 32311373 DOI: 10.1016/j.pharmthera.2020.107551] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
66 Fernández-Ruiz J, Galve-Roperh I, Sagredo O, Guzmán M. Possible therapeutic applications of cannabis in the neuropsychopharmacology field. Eur Neuropsychopharmacol 2020;36:217-34. [PMID: 32057592 DOI: 10.1016/j.euroneuro.2020.01.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
67 Fullana M, Dunsmoor J, Schruers K, Savage H, Bach D, Harrison B. Human fear conditioning: From neuroscience to the clinic. Behaviour Research and Therapy 2020;124:103528. [DOI: 10.1016/j.brat.2019.103528] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
68 Sierra-Fonseca JA, Parise LF, Flores-Ramirez FJ, Robles EH, Garcia-Carachure I, Iñiguez SD. Dorsal Hippocampus ERK2 Signaling Mediates Anxiolytic-Related Behavior in Male Rats. Chronic Stress (Thousand Oaks) 2019;3. [PMID: 32095734 DOI: 10.1177/2470547019897030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]